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ABSTRACT The inner membrane complex (IMC) of Toxoplasma gondii is a peripheral membrane system that is composed of
flattened alveolar sacs that underlie the plasmamembrane, coupled to a supporting cytoskeletal network. The IMC plays impor-
tant roles in parasite replication, motility, and host cell invasion. Despite these central roles in the biology of the parasite, the
proteins that constitute the IMC are largely unknown. In this study, we have adapted a technique named proximity-dependent
biotin identification (BioID) for use in T. gondii to identify novel components of the IMC. Using IMC proteins in both the alve-
oli and the cytoskeletal network as bait, we have uncovered a total of 19 new IMC proteins in both of these suborganellar com-
partments, two of which we functionally evaluate by gene knockout. Importantly, labeling of IMC proteins using this approach
has revealed a group of proteins that localize to the sutures of the alveolar sacs that have been seen in their entirety in Toxo-
plasma species only by freeze fracture electronmicroscopy. Collectively, our study greatly expands the repertoire of known pro-
teins in the IMC and experimentally validates BioID as a strategy for discovering novel constituents of specific cellular compart-
ments of T. gondii.
IMPORTANCE The identification of binding partners is critical for determining protein function within cellular compartments.
However, discovery of protein-protein interactions within membrane or cytoskeletal compartments is challenging, particularly
for transient or unstable interactions that are often disrupted by experimental manipulation of these compartments. To circum-
vent these problems, we adapted an in vivo biotinylation technique called BioID for Toxoplasma species to identify binding
partners and proximal proteins within native cellular environments. We used BioID to identify 19 novel proteins in the parasite
IMC, an organelle consisting of fused membrane sacs and an underlying cytoskeleton, whose protein composition is largely un-
known.We also demonstrate the power of BioID for targeted discovery of proteins within specific compartments, such as the
IMC cytoskeleton. In addition, we uncovered a new group of proteins localizing to the alveolar sutures of the IMC. BioID prom-
ises to reveal new insights on protein constituents and interactions within cellular compartments of Toxoplasma.
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Apicomplexans are a phylum of obligate intracellular parasitesthat cause a significant disease burden in humans and ani-
mals. The most successful of these is Toxoplasma gondii, which
infects approximately one-third of the humanpopulation globally
and is a threat to immunocompromised individuals and neonates
(1). The most notorious apicomplexan parasite is Plasmodium
falciparum, which is the causative agent of malaria, which claims
~1 million lives annually (2). A hallmark of apicomplexans is the
conservation of a number of unique organelles that serve critical
roles in parasite biology and thus are attractive targets for the
development of novel therapeutic interventions.
One of these unique organelles is the innermembrane complex
(IMC), which consists of two distinct elements: a series of flat-
tenedmembrane sacs called alveoli underlying the parasite plasma
membrane and a supporting rigid cytoskeletal network of inter-
mediate filaments (3, 4). In Toxoplasma species, the alveolar sacs
of the IMC are arranged as three rows of fused rectangular mem-
brane plates, sutured together like a quilt, and capped by a single
large alveolar plate at the apical end of the parasite (5). While
Plasmodiummerozoites appear to possess only a single alveolar
sac, distinct segmented plates that are sutured together are vis-
ible in Plasmodium gametocytes (6, 7). In apicomplexans, the
alveolar sacs and underlying cytoskeleton are layered on top
of subpellicular microtubules emanating from an apical
microtubule-organizing center (8).
The IMChas important functions in parasitemotility, host cell
invasion, and intracellular replication. The outer leaflet of the
IMC membrane acts as the anchor for the actin-myosin motor
that powers parasite gliding and invasion (9, 10). In addition, the
IMC serves as the structural scaffold for the formation of daughter
cells within the mother during asexual reproduction. In Toxo-
plasma, two daughter buds arise from the maternal parasite, a
process called endodyogeny, while in Plasmodium, multiple
daughters are formed, termed merogony (11). The nascent IMC
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appears at the onset of bud formation, and replicated organelles
are packaged within this compartment as the buds elongate. The
daughter buds complete their maturation by adopting the mater-
nal plasma membrane.
Despite the crucial roles of the IMC, the protein composition
of this cellular compartment is still largely unknown. Themajority
of IMC proteins that have been identified to date belong to a
family of articulin-like proteins called alveolins, which are char-
acterized by conserved repeatmotifs flanked by variable sequences
(12, 13). These proteins are one of the distinguishing hallmarks of
theAlveolata infrakingdom that includes apicomplexans, dinofla-
gellates, and ciliates. In apicomplexans, the alveolins form part of
the cytoskeletal network that provides structural stability to the
IMC (8).
Even fewer proteins have been localized to the alveolar sub-
compartment of the IMC. Some of these include components of
the parasite actin-myosin motor, such as Gap40, Gap45, and
Gap50,which forma complex that recruits themyosinmachinery,
including MyoA and MLC1, to the IMC (14–16). Another subset
of proteins in the membrane sacs is the IMC subcompartment
proteins (ISP1, -2, -3, and -4), which are tethered to the mem-
brane bilayers via posttranslational acylations (17, 18). In
T. gondii, each ISP localizes to distinct subcompartments of the
IMC, which may be delineated by specific subsets of alveoli (17,
18). For example, ISP1 is found exclusively in the apical cap, while
ISP2 and -4 are present in the center of the IMC but not the cap or
base of the parasite. ISP3, on the other hand, localizes to the center
and the base of the IMC. Although their precise functions are
unknown, the ISPs appear to be involved in daughter bud forma-
tion, as disruption of ISP2 leads to a dysregulation of
endodyogeny (17).
The paucity of characterized IMC proteins led us to identify
new protein constituents of this organelle.We utilized a technique
named BioID that has been developed to uncover novel proteins
and elucidate complex networks of protein-protein interactions
(19). The BioID approach relies on the proximity-dependent bi-
otinylation of interacting partners and proximal proteins by a
promiscuous biotin ligase, BirA*, that is fused to the protein of
interest. BirA* contains a mutation that abolishes substrate spec-
ificity, allowing it to label proteins interacting with or proximal to
the ligase-target protein fusionwithin its native environment. The
biotinylated partners or near neighbors can then be affinity puri-
fied for identification by mass spectrometry. The method has
proved particularly valuable for cytoskeletal or membrane-bound
bait proteins, which are solubilized only under harsh detergent
conditions that often disrupt protein-protein interactions in stan-
dard immunoprecipitation assays. A further advantage of BioID is
the ability to capture transient or weak interactions that could be
missed by other techniques. This approach has been successfully
used to uncover new components of the nuclear lamina, nuclear
pore, and centrioles in mammalian cells, as well as novel bilobe
proteins in Trypanosoma brucei (19–22).
We adapted the BioID technique forT. gondii and, as a proof of
principle, used the IMCmembrane protein ISP3 as bait to identify
novel IMC proteins. We demonstrate that the ISP3-BirA* fusion
localizes properly to the IMC, is catalytically active, and labels
previously described IMCproteins aswell as novel targets. A num-
ber of these targets were verified by epitope tagging, thereby vali-
dating our approach. We further characterized two of these pro-
teins by gene disruption and show that one of them appears to be
essential in Toxoplasma. To evaluate labeling in a different subor-
ganellar compartment of the IMC, we then applied the BioID
approach to a novel IMC cytoskeletal network protein that is re-
stricted to the apical cap. An array of known and novel targets was
again identified, of which a selection of new targets were verified
by localization. Of particular interest, we uncovered a group of
proteins that localize to the transverse and longitudinal sutures of
the rectangular alveolar plates and demonstrate that these novel
constituents associate with both the membrane and cytoskeletal
elements of the IMC. Together, these studies establish a method-
ology for identifying novel proteins in Toxoplasma subcellular
compartments, substantially increase the repertoire of known
IMC proteins, and provide a foundation for evaluating protein-
protein interactions in the IMC.
RESULTS
ISP3-BirA* biotinylates proteins in the IMC. To identify novel
IMC components by BioID, we generated a construct containing
ISP3 fused to BirA* with a C-terminal hemagglutinin (HA) tag,
driven from the ISP3 promoter (Fig. 1A). The ISP3-BirA* fusion
was integrated into the genome of RHhpt (parental) parasites,
and localization of the fusion was assessed by immunofluores-
cence assay (IFA). As expected, we observed staining in the central
and posterior subcompartments of the IMC but not in the apical
cap (Fig. 1B), a pattern consistent with endogenous ISP3 (17).
Correct IMC localization was confirmed by colocalization with
IMC3 (see Fig. S1A in the supplemental material).
To determine if ISP3-BirA* could label proximal proteins in
the IMC, we grew parasites in medium supplemented with biotin
and stained for biotinylated proteins using fluorophore-
conjugated streptavidin. Wild-type T. gondii parasites have en-
dogenously biotinylated proteins in the apicoplast (and to a lesser
degree in the mitochondria) that are labeled by streptavidin, thus
representing the substantial background of this method in Toxo-
plasma comparedwith other cell types (Fig. 1B, top) (23). In ISP3-
BirA*-expressing parasites, we also detected robust streptavidin
staining in the periphery that colocalized with ISP3-BirA*, indi-
cating that the biotin ligase fusion was active and labeled proteins
in the IMC (Fig. 1B, middle). Surprisingly, while ISP3-BirA* was
enriched in daughter buds during endodyogeny (see Fig. S1A),
lower but detectable amounts of biotinylationwere seen in daugh-
ter buds (Fig. 1B, bottom).
We then assessed the labeling of T. gondii proteins by ISP3-
BirA* in whole-cell lysates by Western blotting with a
streptavidin-horseradish peroxidase (HRP) probe. Although
background biotinylated proteins were detectable in parental ly-
sates when the blot was overexposed (see Fig. S1B), there was a
significant increase in biotinylated proteins in lysates of ISP3-
BirA* parasites, and only when biotin was present in the growth
medium (Fig. 1C). These labeled proteins were unique to ISP3-
BirA* parasites and did not appear to correspond to background
proteins from the parental line. Collectively, these data demon-
strate that ISP3-BirA* is active and biotinylates proteins at the
parasite periphery.
Identification of novel IMC proteins by BioID. To identify
targets labeled by ISP3-BirA*, we affinity purified biotinylated
proteins from parasite lysates for MuDPIT mass spectrometric
analysis. Biotinylated proteins fromboth parental and ISP3-BirA*
lysates were significantly enriched using streptavidin-conjugated
magnetic beads (Fig. 2A). Proteins identified by mass spectrome-
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try that were unique to or significantly enriched in ISP3-BirA*
samples were scored as hits based on the number of identified
spectra and unique peptides (see Table S1 in the supplemental
material). The highest-scoring protein in our data set was the ISP3
bait, which is in agreement with previous BioID studies in which
the bait-BirA* fusion biotinylated itself and was the top hit (19–
22). Importantly, some of the highest-scoring hits in our data set
included proteins known to associate with IMC membranes:
MLC1,GAP45,GAP50,HSP20, Rab11b, and ISP1 (14–17, 24, 25).
In addition, proteins in the IMC cytoskeletal network, such as
IMCs 1, 10, and 14, were enriched in our data set (4, 12). These
data indicate that ISP3-BirA* biotinylates proteins in both the
membrane sacs and the underlying network of the IMC.
Next, we utilized gene expression data to filter hits from our
BioID data set for further investigation (summarized in Table 1).
IMC proteins are synthesized de novo during endodyogeny, with
their gene expression peaking during each round of daughter bud
formation at the S and/or M phase (26). We selected a group of
hypothetical proteins with this signature cyclical expression pat-
tern similar to known IMC proteins (see Fig. S2A in the supple-
mentalmaterial) and determined their localization in parasites via
epitope tagging at their C termini.
Characterization of novel IMC proteins identified by
BioID. Among our ISP3-BirA* hits, we epitope-tagged six pro-
teins that shared the same localization inparasites as ISP3:TgGT1_
286580 (here referred to as IMC17), TgGT1_295360 (IMC18),
TgGT_217510 (IMC19), TgGT1_271930 (IMC20), TgGT1_
232030 (IMC21), andTgGT1_313380 (Table 1).One of these pro-
teins, TgGT1_313380, had been independently identified from a
purification of the MORN1 basal complex, designated ILP1, and
characterized elsewhere (27). These proteins have no known func-
tions (Table 1), although IMC17 was annotated as a putative ly-
sophospholipase based on an / hydrolase fold predicted by
BLAST analysis (28). We localized these hits to the central and
basal subcompartments of the IMC but not in the apical cap
(Fig. 2B), consistent with proximal biotinylation by ISP3-BirA*.
In agreement with the preferential labeling of the maternal IMC
by the ISP3-BirA fusion (Fig. 1B, bottom), IMCs 17/18/20 appear
to be deposited onto the maternal IMC after endodyogeny and
were not detected in daughter buds (see Fig. S2B in the supple-
mental material). In contrast, IMCs 19/21 were detected in both
the maternal IMC and nascent daughter buds, as shown by colo-
calization with IMC3 during endodyogeny (see Fig. S2C).
Next, we used detergent extraction assays to determine
whether these IMC proteins are associated with the membrane
sacs or the underlying cytoskeleton (Fig. 2C). Proteins embedded
in the IMC network (such as the alveolins) are resistant to extrac-
tion by the nonionic detergent Triton X-100, whereas proteins
attached to the membrane sacs (such as the ISPs) are solubilized
under these conditions (4). IMCs 18/19/20 were entirely resistant
to extraction by Triton X-100, indicating these proteins are an-
chored into the network of the IMC. IMC17 was partially soluble
in these extraction assays, suggesting an association with the un-
derlying cytoskeleton that is not as firm as these other novel IMC
proteins or alveolins. In contrast, IMC21 appears to localize to the
membrane sacs, as it was solubilized in detergent. This result is
supported by the presence of a predicted palmitoylation site (a
cysteine residue at position 2) that may mediate tethering to the
IMC membranes. The identification of hits from both the mem-
brane sacs and the underlying cytoskeleton indicates that ISP3-
BirA* labels proteins in both of these IMC suborganellar compart-
ments.
In addition to these proteins in the central/posterior regions
of the IMC, we also localized two proteins to the apical cap of the
FIG 1 ISP3-BirA* biotinylates proteins in the parasite IMC. (A) Diagram of the expression cassette encoding ISP3 fused to BirA*, plus a C-terminal 3 HA
epitope tag, driven by the ISP3 promoter. (B) IFA of ISP3-BirA*-expressing parasites, grown for 24 h with or without biotin. ISP3-BirA* localizes to the parasite
periphery and biotinylates proteins in a biotin-dependent manner. Endogenously biotinylated proteins in the apicoplast are detectable as the background even
in the absence of biotin. Bottompanel, ISP3-BirA* biotinylation activity is detectable but not enriched in daughter buds (arrows). Red,mouse anti-HA antibody;
green, streptavidin-Alexa 488. Scale bar  2 m. (C) Western blot comparing the profile of biotinylated proteins from lysates of parental and ISP3-BirA*
parasites.
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parasite: TgGT1_311840 and TgGT1_250820. TgGT1_311840
was one of the highest-scoring hits on our data set. TgGT1_
250820, on the other hand, had amuch lower rank but was chosen
for analysis based on its IMC-like cyclical expression pattern (see
Fig. S2A). Staining of TgGT1_311840 and TgGT1_250820 over-
lapped perfectly with that of ISP1 in both mature and dividing
parasites (Fig. 2D and Fig. S2C in the supplemental material, re-
spectively), demonstrating these proteins also localize to the nas-
cent IMCduring replication.WesubsequentlydesignatedTgGT1_
311840 and TgGT1_250820 as apical cap protein 1 (AC1) and
AC2. Consistent with extraction data from other ISP3 BioID hits,
we found these two apical cap proteins reside in separate subcom-
partments of the IMC: AC1 associates with the membrane sacs
(consistent with a predicted palmitoylation site at Cys-8), while
AC2 is anchored into the cytoskeletal network (Fig. 2E). Two ad-
ditional proteins from the ISP3 BioID data set were localized to a
unique compartment of the IMC and are discussed below. As
expected, not all proteins chosen for endogenous tagging localized
to the IMC: three proteins, TgGT1_240570, TgGT1_320740, and
TgGT1_232340, stained punctate vesicular structures throughout
the parasite (see Table S1 and Fig. S2D in the supplemental mate-
rial).
Of these new IMCproteins that we localized, we chose to func-
tionally characterize IMC18 and ILP1 by gene disruption using a
combinatorial epitope-tagging/Cre-lox strategy (see the approach
in Fig. S3A in the supplemental material). This strategy is a mod-
ification of the Cre-lox gene excision system previously estab-
lished for Toxoplasma (29). We endogenously tagged both the
target gene and the upstream gene with an epitope tag followed
downstream by an loxP site, thereby flanking the target gene with
loxP sites. We performed this genetic engineering in DiCre-ku80::
KillerRedfloxYFP parasites that express inducible Cre recombinase
and also activate yellow fluorescent protein (YFP) expression
upon induction with rapamycin (30). In both target strains, we
observed the loss of the 3HA-tagged target protein at the IMCas
well as concomitant expression of YFP upon induction of Cre
activity (Fig. 3A and C). Disruption of IMC18 did not have any
observable gross effects on parasite morphology, as assessed by
FIG 2 Identification of novel IMC proteins by ISP3 BioID. (A)Western blot showing enrichment of biotinylated proteins from parental and ISP3-BirA* lysates
by streptavidin magnetic beads, as assessed by monitoring of the precolumn (P), flowthrough (F), and elution (E) fractions. (B) ISP3 BioID hits were localized
to the IMC by endogenous tagging, where they colocalize with the IMC markers IMCs 1/3. Similar to ISP3-BirA*, these proteins stain the central and basal
subcompartments of the IMCbut not the apical cap. Red,mouse or rabbit anti-HA antibodies; green,mouse anti-IMC1 or rat anti-IMC3 antibodies. Scale bar
2m. (C)Western blots showing detergent extraction analysis of ISP3 BioID hits. The total lysate (T) was partitioned into the insoluble pellet (P) or soluble (S)
fractions. Fractionation was monitored using IMC1 (insoluble) and ISP3 (soluble) controls. (D) IFA showing two additional ISP3 BioID hits that localize to the
apical cap demarked by ISP1. Red, rabbit anti-HA antibody; green, mouse anti-ISP1 antibody. (E) Detergent extractions of ACs 1/2 as described in part C.
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IFA (Fig. 3A, bottom), or parasite growth, as measured by plaque
assays (data not shown). In contrast, ilp1 vacuoles were highly
disordered and contained morphologically abnormal parasites
that appeared enlarged and/or malformed (Fig. 3C), defects that
were reminiscent of ILP1-overexpressing parasites (27). In addi-
tion, we observed a general mislocalization of organelles, such as
mitochondria and apicoplasts, within parasites lacking ILP1
(Fig. 3D).Wewere unable to successfully clone an ILP1-null, YFP-
positive parasite after repeated rounds of limiting dilution from
knockout-positive pools, suggesting ablation of this gene is lethal.
AC2-BirA* biotinylates proteins in the apical cap of T. gon-
dii. We also wanted to explore whether the BioID approach was
applicable to the cytoskeletal network of the IMC. We simultane-
ously chose to focus on proteins in the apical cap, and thus we
fused BirA* to the cytoskeletal apical cap protein AC2 (Fig. 4A). In
this case, we engineered the BirA* sequence into a vector for en-
dogenous tagging and integrated it into the AC2 locus by homol-
ogous recombination. The resulting AC2-BirA* fusion localized
correctly to the apical cap and also labeled proteins in the apex of
mature and dividing parasites upon addition of biotin, as detected
by streptavidin staining that colocalized with the bait protein
(Fig. 4A).
To identify the proteins labeled by AC2-BirA*, we again puri-
fied biotinylated proteins from parasites and analyzed them by
MuDPIT mass spectrometry (see Table S2 in the supplemental
material). Our top hits were enriched for the alveolins IMC1, -3,
-4, -6, -7, -10, -12, -13, and -14 (12), indicating that AC2-BirA*
preferentially labels proteins in the IMC cytoskeletal network. In
addition, several IMC proteins prominent in the apical cap, in-
cluding ISP1, PhIL1, and IMC11, scored highly in our experiment
(12, 17, 31). These hits suggest that the BirA* ligase, when fused to
the appropriate bait protein, can be used to selectively biotinylate
proteins in specific suborganellar compartments of the parasite.
Identification of cytoskeletal proteins in the apical cap of
T. gondii by BioID. To determine if AC2-BirA* labeled novel
targets in the apical cap, we localized several hypothetical proteins
with IMC-like cyclical expression patterns from our hits (see
Fig. S4A in the supplemental material). By endogenous tagging,
we identified 5 novel proteins in the apical cap: TgGT1_308860
(designated AC3), TgGT1_214880 (AC4), TgGT1_235380 (AC5),
TgGT1_251850 (AC6), and TgGT1_225690 (AC7). All of these
proteins colocalized with the apical cap marker ISP1 in both pa-
rental and daughter parasites (Fig. 4B; see also Fig. S4B). In addi-
tion, we localized 3 proteins from this data set to the central
and posterior regions of the IMC: TgGT1_316340 (IMC22),
TgGT1_304670 (IMC23), and TgGT1_258470 (IMC24), all of
which colocalized with IMC3 (Fig. 4C). Importantly, we deter-
mined using detergent extraction assays that 7 of these 8 proteins
reside in the IMC cytoskeleton (see Fig. S5 in the supplemental
material), validating BioID as an approach to identify cytoskeletal
TABLE 1 Summary of IMC proteins identified in this studya
Name
TgGT1 gene
identifier Localization
TX-100
extraction Daughters?
P. falciparum
PF3D7 identifier Mol wt Description/note(s)
IMC17 286580 Center/base Insoluble No None 107 Contains predicted / hydrolase fold
IMC18 295360 Center/base Insoluble No None 30 Knockout produced no apparent phenotype
in vitro; Predicted palmitoylation site at
Cys-266
IMC19 217510 Center/base Insoluble Yes None 42 Hypothetical protein; predicted
palmitoylation site at Cys-362; signal
brighter in posterior IMC
IMC20 271930 Center/base Insoluble No 1447500 26 Hypothetical protein
IMC21 232030 Center/base Soluble Yes None 23 Predicted palmitoylation site at Cys-2;
signal brighter in posterior IMC
IMC22 316340 Center/base Insoluble No None 26 Hypothetical protein
IMC23 304670 Center/base Insoluble Yes None 38 Contains predicted leucine-rich repeats
IMC24 258470 Center/base Insoluble No None 31 Hypothetical protein
AC1 311480 Apical cap Soluble Yes None 42 Detected in daughters before ISP1;
predicted palmitoylation site at Cys-8
AC2 250820 Apical cap Insoluble Yes None 121 Detected in daughters after ISP1
AC3 308860 Apical cap Insoluble Yes None 66 Detected in daughters after ISP1
AC4 214880 Apical cap Insoluble Yes None 98 Detected in daughters after ISP1
AC5 235380 Apical cap Insoluble Yes None 65 Detected primarily in daughters (low signal
in maternal IMC) and before ISP1
AC6 251850 Apical cap Soluble Yes 1423300 117 Predicted serine/threonine protein
phosphatase; detected in daughters after
ISP1
AC7 225690 Apical cap Insoluble Yes None 194 Predicted palmitoylation sites at Cys-1255,
Cys-1401
ISC1 235340 Sutures Insoluble Yes 1341500 77 Predicted palmitoylation site at Cys-573
ISC2 219170 Sutures Soluble Yes None 33 Hypothetical protein
ISC3 220930 Sutures Soluble Yes 1431900 74 8 predicted transmembrane domains;
enriched in daughter cells compared to
other ISCs
ISC4 305930 Sutures Insoluble Yes None 26 Predicted palmitoylation site at Cys-3
a Predicted palmitoylation sites scoring8.0 in CSS Palm 4.0 (http://csspalm.biocuckoo.org) are listed. No predicted myristoylation sites were detected
(http://mendel.imp.ac.at/myristate/SUPLpredictor.htm).
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components in T. gondii parasites. Consistent with our previous
BioID experiment, we also tagged two proteins that are not in the
IMC: TgGT1_249870 labeled cytoplasmic puncta in the parasite
while TgGT1_232130 localized to the subpellicular microtubules
(see Table S2 and Fig. S4C). During the course of these studies,
AC5 and TgGT1_232130 were detected by mass spectrometric
analysis of immunoprecipitations of the subpellicular microtubule-
associated protein TrxL1, although their localization was not de-
termined (32).
Identification of proteins that localize to the alveolar sutures
of the IMC. The IMC alveoli are organized as a patchwork of
rectangular plates plus the single cone-shaped plate termed the
apical cap (Fig. 5A). These plates are sutured together by unknown
components to form the IMC. Recently, a protein called CBAP/
SIP was identified that appears to label the transverse junctions of
the IMC plates, as well as more prominent rings at the apical and
basal ends of the parasite (33, 34). One of the most remarkable
findings of our IMC BioID approach was the discovery of three
proteins (TgGT1_235340 and TgGT1_219170 from the ISP3
BioID data set and TgGT1_220930 from AC2 BioID) that localize
to the precise pattern expected for the IMC sutures. This suture
staining pattern labels both longitudinal and transverse structures
extending along the center and posterior of the IMC (Fig. 5B) but
not the apical cap or subpellicular microtubules (see Fig. S6A in
the supplementalmaterial) (32). This staining agrees well with the
approximate number, size, and shape of the IMC plates shown in
freeze fracture electron microscopy studies (5). In independent
gene-tagging studies in our lab, we also discovered a fourth IMC
suture protein that we also report here (TgGT1_305930). Since
TgGT1_235340, TgGT1_219170, TgGT1_220930, and TgGT1_
305930 are the first markers that delineate the entirety (e.g., both
the longitudinal and transverse) of the sutures between the mem-
brane plates, we designated these proteins IMC suture compo-
nents (ISCs) 1 to 4, respectively.
While ISCs 1, 2, and 4 do not contain any apparent functional
domains by BLAST analyses, ISC3 contains similarity to choline
transporter-like proteins, which may suggest a role in IMCmem-
brane biogenesis (35). Each of the ISCs can be detected on the
nascent IMC during endodyogeny, although ISC3 is much more
prominent in the budding daughters compared to the other ISCs
(see Fig. S6B). ISC3 is also unique in that it contains 8 predicted
transmembrane domains that presumably span the alveolarmem-
branes. In agreement with this, ISC3 is released with other IMC
membrane proteins upon detergent extraction (see Fig. S6C).
ISC2 is also soluble in these assays, although it lacks predicted
transmembrane domains or acylation sites, suggesting indirect
attachment to the IMC membranes and/or a loose interaction
with the cytoskeleton. Surprisingly, ISCs 1/4 appear to be firmly
embedded into the IMC cytoskeleton but also have predicted pal-
mitoylation sites that may tether them to the membranes (Ta-
ble 1). Taken together, these data indicate that there are both
membrane and cytoskeletal components of the IMC sutures.
We further examined the ISCs with superresolution microscopy
and in relation to other IMC proteins. We visualized the brightest-
staining ISC (ISC3)using both confocal and superresolution (STED)
microscopy and found that the longitudinal and transverse IMC su-
FIG 3 Gene disruption of selected ISP3 BioID hits using a combinatorial epitope-tagging/Cre-lox strategy. (A) IFA showing parasites with IMC18 endogenously
tagged in theDiCre-ku80::KillerRedfloxYFP background (30), grownwith orwithout rapamycin induces Cre recombinase, resulting in excision of the tagged gene.
Cre-mediated recombination is monitored by a chromosomal copy of loxP-KillerRed-loxP-YFP under the control of the p5RT70 promoter, which drives YFP
expression after the floxed KillerRed gene is excised. Top, untreated parasites. Green, mouse anti-HA antibody. Bottom, ablation of IMC18 had no observable
gross effects on parasite morphology as assessed by IFA. Red, mouse anti-HA antibody. Scale bar  2 m. (B) IFA showing untreated parasites with ILP1
endogenously tagged in the same background. Green, mouse anti-HA antibody. (C) Disruption of ILP1 leads to disordered vacuoles containing aberrant and
misshapen parasites. Red, mouse anti-HA antibody. Scale bar 5m. (D) IFA showingmislocalizedmitochondria (top) and apicoplasts (bottom) in ILP1-null
parasites. Red, mouse anti-F1  or mouse anti-ATrx1 antibody.
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tures resolved as puncta rather than continuous lines at higher reso-
lutions (Fig. 5C). We also costained ISC2 with CBAP/SIP, which
showed colocalization at the transverse sutures (Fig. 5D), in agree-
mentwith their initial discoveries (33, 34). Finally, we had previously
hypothesized that the posterior boundary of ISP2, which localizes to
the central subcompartment of the IMC, is delineated by discrete
alveolar plates (17). To examine this possibility, we colocalized ISP2
with ISC2 and found that the ISP2 subcompartment does indeed
terminate at an alveolar junction, as the edges of the ISP2 boundary
aligned perfectly with a transverse suture (Fig. 5E). These data pro-
vide support for a model in which the IMC subcompartments are
defined by specific subsets of alveoli (17).
DISCUSSION
TheToxoplasma IMC consists of distinctmembrane and cytoskel-
etal elements that can be problematic for identifying protein-
protein interactions through conventional methods, particularly
transient or weaker interactions. In addition, only a small number
of IMC proteins (~30) have been identified, and the IMC total
protein composition is largely unknown. To circumvent these
problems, we adapted the BioID technique for T. gondii and dem-
onstrate that BirA* fusions can biotinylate a robust number of
proteins in the IMC. These proteins were identified via MuDPIT
despite the inherent background of endogenous biotinylated pro-
teins present in the apicoplast (23). Determining whether these
proteins are bona fide interacting partners or merely proximal
proteins will need to be addressed using other approaches, such as
coimmunoprecipitations, two-hybrid assays, or split green fluo-
rescent protein (GFP). However, we anticipate that the highest-
scoring mass spectrometry hits are more likely to represent true
binding partners. Additional experimental replicates and reverse
BioID experiments with prey proteins will also help to verify in-
teractions and may reveal important interaction networks within
the IMC.
We chose the IMC membrane protein ISP3 as bait for the ini-
tial BirA* fusion, because ISP3 can be fused to a large tag, such as
YFP, and traffic correctly to the IMC (17). Because ISP3 is inserted
into the IMC membranes by coordinated acylations (17), we hy-
pothesized that ISP3-BirA* should label proteins in the alveoli and
potentially some in the adjacent IMC cytoskeleton. Indeed, our
FIG 4 Identification of novel IMC proteins by AC2 BioID. (A) IFA of AC2-BirA*-expressing parasites, grown for 24 h with or without biotin. AC2-BirA*
biotinylates proteins in the apical cap inmature (middle) and daughter (bottom, arrows) parasites. Red, mouse anti-HA antibody; green, streptavidin-Alexa488.
Scale bar 2m. (B) IFA showing AC2BioID hits localized to the apical cap demarked by ISP1. Red, rabbit anti-HA antibody; green,mouse anti-ISP1 antibody.
(C) Three additional AC2 BioID hits localized to the center and posterior of the IMC, as assessed by costaining with IMC3. Red, mouse anti-HA antibody; green,
rat anti-IMC3 antibody.
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ISP3 BioID data set contains known and novel proteins from both
suborganellar compartments (see Table S1 in the supplemental
material). Surprisingly, while the ISP3-BirA* fusion targets prop-
erly and is enriched in daughter buds like endogenous ISP3 (17),
its biotinylation activity appears to be mostly confined to the ma-
ternal IMC (Fig. 1B, bottom). This suggests that biotinylation ac-
tivity of the fusion is altered during endodyogeny ormodulated by
the surrounding compartment. Alternatively, the lower signal in
the nascent IMC could be attributed to the fact that daughter buds
have less time to accumulate the biotinylation signal than the ma-
ternal IMC. In agreement with this activity, the novel proteins
identified by ISP3 BioID are present in, and in some cases re-
stricted to, the maternal IMC. The biotinylation of ISCs by ISP3-
BirA* is not surprising, as the sutures appear to be in direct contact
with the alveolar membrane sacs. The identification of two new
apical cap proteins via ISP3 BioID is less expected but could be
attributed to labeling at the junctions between the cap and its
neighboring alveolar plates or during early stages of daughter bud
formation. It is also clear that ISP3-BirA* does not label the entire
subcompartment, as our data set did not include the ISP family
members ISP2 and ISP4, whose localizations partially overlap
ISP3 in the IMC (17, 18). We anticipate that the extent of biotiny-
lation by BirA* fusions will be dependent on the activity of the
particular bait used as well as its proximity to other proteins. It is
also important to note that filtering our hits from both data sets
described here based on IMC-like gene expression profiles yielded
proteins that do not localize to the IMC. Four of these proteins
stained punctate vesicular structures in the parasite and one la-
beled the subpellicular microtubules (see Table S1 and S2 and
Fig. S2D and S4C in the supplemental material). Although they
were enriched above background proteins from parental para-
sites, it is not known whether these five hits represent true inter-
actors/near neighbors of our bait proteins.
To begin functional analyses of these novel IMC proteins, we
used amodification of the Cre-lox system developed previously to
disrupt the genes encoding IMC18 and ILP1 (29). This modified
system requires that both the target gene and the upstream gene
are arranged in the same orientation in the genome and amenable
to endogenous tagging, which results in loxP sites flanking the
gene of interest (developed by theM.W.White lab; see Fig. S3A in
the supplemental material). This approach has the added benefit
of localizing the upstream gene product, if it is unknown (see
Fig. S3B and D). imc18 parasites displayed no apparent pheno-
type in vitro, although this result should be taken with caution, as
significant compensation has recently been reported in other gene
knockouts in T. gondii (36–38). IMC18 does not appear to have
paralogs that are detectable by BLAST analysis (data not shown),
but we cannot rule out the possibility of other IMC proteins pro-
viding functional redundancy. In contrast, disruption of ILP1 re-
sulted in gross morphological defects (Fig. 3C andD) and appears
to be lethal to the parasite. These data are in agreement with over-
expression studies of ILP1 in Toxoplasma, which resulted in aber-
FIG 5 Identification of proteins that localize to the alveolar sutures of the IMC. (A) Diagram of the IMCmembrane sacs subdivided into cap, central, and basal
compartments, delineated by the sutures between eachmembrane sac (green). (B) IFA showing four novel ISC proteins that localize to the IMC sutures. Staining
corresponding to both transverse and longitudinal sutures is detectable in parasites. Red, mouse anti-HA antibody. Scale bar 2 m. (C) Comparison of ISC3
staining as visualized by confocal (left) and STEDmicroscopy (right). Red,mouse anti-HAantibody. Scale bar 1m. (D) IFA showing that ISC2 andCBAP/SIP
colocalize at the transverse sutures of the IMC (arrowheads). Red, rabbit anti-HA antibody; green, mouse anti-Myc antibody. (E) IFA showing that the sutures,
labeled by ISC2, form the posterior boundary (arrows) for the central subcompartment of the IMC, demarked by staining of ISP2 in parasites transfected with
pISP2-HA-HPT. Red, rabbit anti-HA antibody; green, mouse anti-Myc antibody.
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rant nuclei and IMC cytoskeletons (27). Similarly, ablation of the
ILP1 homolog in Plasmodium berghei produced enlarged, swollen
parasites with microtubule and motility defects (39). While the
ILP1 homolog is not essential in P. berghei, we were unable to
obtain a viable T. gondiiilp1mutant in spite of extensive rounds
of cloningCre-induced knockout parasites. It is possible that Plas-
modium contains compensatory factors and that their homologs
in Toxoplasma are either not present or have lost their ability to
suffice in the absence of ILP1. While the tagging/knockout ap-
proach used here is rapid and inducible with rapamycin only a
subset of the genes in our ISP3BioIDdata set have the correct gene
orientation for this approach. The development of clustered reg-
ularly interspaced short palindromic repeat (CRISPR)/Cas9 gene
disruption systems in T. gondii will facilitate the functional anal-
ysis of large groups of novel genes, such as those identified in this
study (40, 41).
The results from our second BioID experiment with AC2 dem-
onstrate the utility of the technique for exploring cytoskeletal net-
works in T. gondii and for the targeted enrichment of proteins
from specific subcompartments of the parasite. In this case, we
observed robust labeling of known and novel cytoskeletal proteins
in the IMC, many of which are restricted to the apical cap (see
Table S2). Interestingly, we found that the 15 novel IMC proteins
identified here segregated into two groups of proteins: those
that localize to the central and basal subcompartments of the IMC
and those that reside in the apical cap (as opposed to IMC1,
which stains throughout the IMC). Our results, taken together
with other known IMC proteins (12, 17), suggest that the IMC
is a highly compartmentalized organelle containing many
compartment-specific proteins. As has been previously described
for alveolins (12), we observed that some apical cap proteins were
detected earlier or later in daughter buds relative to ISP1 (e.g.,
AC1 is visible on buds before ISP1, while AC4 is detected after
[summarized in Table 1]). Analyzing precisely when each of these
markers is detected on the nascent IMCwill help provide a spatial
and temporal understanding of daughter bud formation during
endodyogeny.
Perhaps the most intriguing group of proteins uncovered in
this study is the ISCs, which appear to specifically label the sutures
of the IMC. These proteins localize to both transverse and longi-
tudinal sutures, clearly demarking the rectangular alveolar sacs of
the IMC (Fig. 5B). By labeling the entirety of the sutures, the ISCs
support the localization ofCBAP/SIP to the transverse sutures and
indicate that there are differences in protein composition between
transverse and longitudinal sutures (33, 34). The staining pattern
of MAL13P1.228, a P. falciparum-specific IMC protein reported
to localize primarily to rectangular transverse sutures in gameto-
cytes, appears to be more reminiscent of CBAP/SIP than the ISCs
(6). Importantly, the ISCs also provide evidence that the IMC
subcompartments, delineated by individual ISPs, represent dis-
tinct subsets of alveolar plates (17). Although the precise mecha-
nisms targeting ISPs to their subcompartments are unknown, it is
possible that these subsets of alveoli express specific enzymes
(such as palmitoyl acyltransferases) or receptors that facilitate
proper ISP localization.
Interestingly, the ISCs appear to associate with both the mem-
brane and cytoskeletal elements of the IMC.Of the ISCs identified
here, ISC3 most closely fits what might be predicted of a mem-
brane suture protein in that it contains 8 predicted transmem-
brane domains that are presumably anchored in the alveolar sacs
and released upon detergent extraction (see Fig. S6C). ISC3 is also
similar to choline transporter-like proteins, which import choline
for the synthesis of phospholipids for cellular membranes (35).
Thismay suggest a role for ISC3 in choline acquisition for building
IMCmembranes. In contrast, ISCs 1/4 are embedded in the cyto-
skeleton andmay provide amolecular bridge between the sutured
alveolar sacs and the underlying network. ISC2 is released by de-
tergent extraction but lacks apparent transmembrane domains or
acylation sites that could tether it to the IMC membranes. It is
tempting to speculate that these four ISCs form a complex at the
sutures, with ISC2 linking the membrane-bound ISC3 to the ISCs
anchored in the cytoskeleton. However, additional studies will be
required to elucidate these interactions and determine the func-
tion of the ISCs at the sutures. The ISCs also provide new candi-
date BioID bait proteins that will undoubtedly reveal more con-
stituents of the alveolar sutures and provide clues on how these
ISCs interact to form this critical structure within the parasite.
MATERIALS AND METHODS
Toxoplasma andhost cell culture.TheT. gondiiRHhpt, RHku80hpt,
and modified strains were grown on confluent monolayers of human
foreskin fibroblast (HFF) host cells in Dulbecco’s modified Eagle’s me-
dium (DMEM) supplemented with 10% fetal bovine serum, as previously
described (42).
Antibodies. The following previously described primary antibodies
were used in immunofluorescence (IFA) or Western blot assays: anti-
IMC1 (monoclonal antibody [MAb] 45.15) (43), anti-ISP1 (MAb 7E8)
(17), mouse anti-ISP3 (17), anti-F1 ATP synthase  subunit (MAb 5F4)
(44), anti-ATrx1 (MAb 11G8) (45), anti-ROP7 (MAb 1B10) (46), rabbit
anti-ROP13 (47), and rat anti-IMC3 (12). The hemagglutinin (HA)
epitope was detected with mouse anti-HA (MAb HA.11) (Covance) or
rabbit anti-HA (Invitrogen). The c-Myc epitope was detected withmouse
anti-Myc (MAb 9E10) (NeoMarkers) or rabbit anti-Myc (Sigma).
IFA and Western blotting. For IFA, HFFs were grown to confluence
on coverslips and infected with T. gondii parasites. After 18 to 36 h, the
coverslips were fixed and processed for indirect immunofluorescence as
previously described (48). Primary antibodies were detected by species-
specific secondary antibodies conjugated to Alexa 594/488/350. The cov-
erslips were mounted in Vectashield (Vector Labs) and viewed with an
Axio Imager.Z1 fluorescence microscope (Zeiss) as previously described
(17).
For Western blotting, parasites were lysed in Laemmli sample
buffer (50 mM Tris-HCl [pH 6.8], 10% glycerol, 2% SDS, 1%
2-mercaptoethanol, 0.1% bromophenol blue), and lysates were resolved
by SDS-PAGE and transferred onto nitrocellulosemembranes. Blots were
probed with the indicated primary antibodies, followed by secondary an-
tibodies conjugated to horseradish peroxidase (HRP). Target proteins
were visualized by chemiluminescence.
Second-copy expression of ISP3-BirA*. To generate the ISP3-BirA*
fusion, the BirA* sequence (19) was PCR amplified (P1/P2; see Table S3 in
the supplemental material) and inserted into pISP3-HA-HPT in frame
(17), between the 3= end of ISP3 and the HA epitope tag, to generate
pISP3-BirA*-HA-HPT. One hundred micrograms of the construct was
linearized with HindIII and transfected into RHhpt parasites. The par-
asites were selected with medium containing 50 g/ml mycophenolic
acid-xanthine, cloned by limiting dilution, and screened byWestern blot-
ting and IFA against the HA tag. A clone expressing the correct fusion
protein was selected and designated ISP3-BirA*.
Epitope taggingofBioIDhits.For endogenous taggingof proteins,we
used the plasmids p3HA-LIC-DHFR, p3HA-LIC-HPT, or p3HA-
LIC-CAT (18). For this study, we generated pBirA*-3HA-LIC-DHFR
by inserting the BirA* sequence into p3HA-LIC-DHFR, in frame be-
tween the LIC sites and 3 HA tag. A 3= portion of each gene was PCR
amplified using the designated primers (see Table S3) and inserted into
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the respective plasmid using a ligation-independent cloning approach to
generate a 3HA epitope tag fusion prior to the stop codon of each gene.
One hundred micrograms of each construct was linearized within the
amplicon and transfected into RHku80hpt parasites. Transgenic para-
sites were selected in the appropriate drug medium (containing either
1 M pyrimethamine, 50 g/ml mycophenolic acid-xanthine, or 1 M
chloramphenicol) and cloned by limiting dilution. Clones that had un-
dergone the intended recombination event were screened by IFA and
Western blotting against the 3 HA tag. For Cre-lox knockout experi-
ments, we used the plasmids p3HA-LIC-CAT-loxP and p3Myc-LIC-
HPT-loxP (which contain loxP sites downstream of the drug marker; de-
veloped by the M. W. White lab, University of South Florida) for
endogenously tagging the target gene and its upstream gene, respectively,
in DiCre-ku80::KillerRedfloxYFP parasites (30). Cre-mediated gene exci-
sion was performed as previously described (29).
Detergent extractions. Extracellular parasites were washed in
phosphate-buffered saline (PBS), pelleted, and lysed in 1 ml of 1% Triton
X-100 lysis buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl) supple-
mented with Complete protease inhibitor cocktail (Roche) for 30 min on
ice. Lysateswere centrifuged for 15min at 14,000 g. Equivalent amounts
of total, supernatant, and pellet fractions were separated by SDS-PAGE
and analyzed by Western blotting.
Affinity capture of biotinylated proteins. HFF monolayers infected
with parasites expressing BirA* fusions or the respective parental linewere
grown in medium containing 150 M biotin for 24 h prior to parasite
egress. A total of 150 M of biotin yielded more robust BirA* labeling
within the IMC (which was optimal by 24 h [data not shown]) compared
to 50 M used previously for mammalian cells (19). Extracellular para-
sites were collected, washed in PBS, and lysed in RIPA buffer (50mMTris
[pH 7.5], 150 mMNaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% NP-
40) supplemented with Complete protease inhibitor cocktail (Roche) for
30 min on ice. Lysates were centrifuged for 15 min at 14,000 g to pellet
insoluble debris and then incubated with PureProteome streptavidin
magnetic beads at room temperature for 4 h under gentle agitation. Beads
were collected using magnets and washed five times in RIPA buffer, fol-
lowed by three washes in 8 M urea buffer (50 mM Tris-HCl [pH 7.4],
150mMNaCl). Ten percent of each samplewas boiled in Laemmli sample
buffer, and eluted proteins were analyzed by Western blotting by
streptavidin-HRP prior to mass spectrometry.
Mass spectrometry of biotinylated proteins.Purified proteins bound
to streptavidin beads were reduced, alkylated, and digested by sequential
addition of Lys-C and trypsin proteases (49, 50). The peptidemixture was
desalted using C18 tips and fractionated online using a 75-m inner di-
ameter fritted fused silica capillary column with a 5-m pulled electros-
pray tip and packed in house with 15 cm of Luna C18(2) 3 m reversed-
phase particles. The gradient was delivered by an easy-nLC 1000
ultrahigh-pressure liquid chromatography (UHPLC) system (Thermo
Scientific). Tandem mass spectrometry (MS/MS) spectra were collected
on a Q-Exactive mass spectrometer (Thermo Scientific) (51, 52). Data
analysis was performed using the ProLuCID and DTASelect2 imple-
mented in the Integrated Proteomics pipeline IP2 (Integrated Proteomics
Applications, Inc., San Diego, CA) (53–55). Protein and peptide identifi-
cations were filtered using DTASelect and required a minimum of two
unique peptides per protein and a peptide-level false-positive rate of less
than 5%, as estimated by a decoy database strategy (56). Normalized spec-
tral abundance factor (NSAF) values were calculated as described (57).
Immunocytochemistry and confocal and superresolution imaging.
Extracellular parasites were fixed, laid onto coverslips, and processed for
indirect immunofluorescence as previously described (48). The coverslips
were mounted in ProLong Gold (Molecular Probes) and imaged using a
TCS SP5 MP-STED confocal microscope (Leica Microsystems) as de-
scribed (58). In brief, the ATTO 647N-labeled parasites were imaged on
an avalanche photodiode (APD; PerkinElmer) using an oil immersion
objective (HCX PL APO CS 100/1.40-numerical-apterature STED), a
640-nm pulsed diode laser (PicoQuant) for excitation, and a 750-nm
pulse (Mai Tai Broadband; Spectra-Physics) for STED depletion.
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